The N-terminal domain of the E3L protein of vaccinia virus has sequence similarity to a family of Z-DNA binding proteins of defined three-dimensional structure and it is necessary for pathogenicity in mice. When other Z-DNA-binding domains are substituted for the similar E3L domain, the virus retains its lethality after intracranial inoculation. Mutations decreasing Z-DNA binding in the chimera correlate with decreases in viral pathogenicity, as do analogous mutations in wild-type E3L. A chimeric virus incorporating a related protein that does not bind Z-DNA is not pathogenic, but a mutation that creates Z-DNA binding makes a lethal virus. The ability to bind the Z conformation is thus essential to E3L activity. This finding may allow the design of a class of antiviral agents, including agents against variola (smallpox), which has an almost identical E3L.
V
accinia is a large, DNA-containing poxvirus with Ͼ200 genes, which replicates in the cytoplasm of infected cells (1) . When an adapted strain of vaccinia is given to a mouse, the mouse dies in Ϸ1 week, depending on the dosage and route of infection (2) . The viral E3L gene product has been extensively characterized and is essential for virulence (2) . E3L encodes a 25-kDa protein that has two essential domains (3) ; an N-terminal domain with sequence similarity to the vertebrate Z␣ family of Z-DNA-binding domains (4) , and a C-terminal domain that has a typical double-stranded RNA binding motif (refs. 5-7; Fig. 1 ). Although the N-terminal domain is not required for replication or IFN resistance in cells in culture (6, 7) , it is required for full pathogenesis in mice (2, 8, 9) . The E3L molecule is a conserved common feature of orthopox viruses. In fact, when comparing vaccinia and variola, the agent of smallpox, the N-terminal (Fig.  1b) and C-terminal (not shown) E3L domains are both nearly identical.
By sequence, the N-terminal half of E3L is a member of the Z␣ family of Z-DNA-binding domains (Fig. 1b) . The crystal structures of two Z␣ protein domains, Z␣ ADAR1 ( Fig. 1a ; ref. 10) and Z␣ DLM1 (11) , have been determined complexed to Z-DNA. Z␣ ADAR1 is found at the N terminus of the IFN-inducible (12) RNA editing enzyme double-stranded RNA adenosine deaminase (ADAR1) ( Fig. 1c; ref. 4 ). Z␣ DLM1 is from the tumorrelated DLM-1 protein, which is also IFN induced (13) . Both of these domains consist of a helix-turn-helix motif with an additional ␤-sheet. The structures of Z␣ ADAR1 (10) and Z␣ DLM1 (11) complexed to Z-DNA are very similar, but the amino acid sequence is not conserved, except for those residues that contact DNA (Fig. 1b) . In this article, we ask whether the sequence similarity between the N-terminal domain of the vaccinia E3L protein and the known Z-DNA-binding proteins is reflected in biological activity. By exchanging known Z-DNA-binding domains for the N terminus of viral E3L, we find that these domains are functionally interchangeable. Further insight is provided by exploring mutations in wild-type and chimeric E3L; the choice of mutations was guided by the crystal structures of Z-DNA binding proteins complexed to Z-DNA. The results show that binding to the Z conformation is necessary for E3L biological activity.
Materials and Methods
Cell Culture, Construction, and Amplification of Chimeric Viruses. The construction of chimeric viruses, including the construction of chimeric E3L genes, the introduction of point mutations, and the insertion of these genes into the virus by in vivo recombination are described in detail in Supporting Text, which is published as supporting information on the PNAS web site, www.pnas.org. Standard methods of cell culture were used as well as methods for virus amplification. These are described in detail in Supporting Text. All animal experiments were approved by the Arizona State University Institutional Animal Care and Use Committee.
Circular Dichroism (CD).
The conversion of d(CG) 6 from righthanded B-DNA to left-handed Z-DNA is monitored by measuring changes in CD in the UV (14) . The rate and extent to which the Z␣ ADAR1 protein converts d(CG) 6 from B-DNA to Z-DNA was measured (15) . The proteins used in the CD studies were prepared and purified as described (16) .
Results

Chimeras with Z␣ADAR1 or Z␣DLM1 Exchanged for the N Terminus of E3L
Are Virulent. The N-terminal residues of E3L are essential for virulence. If the first 83 residues are deleted, leaving only the C terminus of E3L (E3L C ), there is dramatically decreased pathogenicity in mice (ref. 2; Fig. 2 ). These 83 residues encompass the Z␣ motif (Fig. 1b) . To examine the importance of Z-DNA binding, a domain swap was carried out in which 67 N-terminal amino acids of E3L were replaced with 64 residues of Z␣ ADAR1 ( Fig. 1 b and c) . In this replacement, Ϸ50 residues were changed. The remaining 14 identical residues include those that contact Z-DNA in the Z␣ ADAR1 crystal structure ( Fig. 1 a and b) . The chimeric virus (Z␣ ADAR1 -E3L C ) retains the wild-type C-terminal E3L domain. This construct was tested by intracranial injection into mice to assay pathogenicity, as described (2) . As shown in Fig. 2 , the Z␣ ADAR1 -E3L C chimeric virus is as pathogenic as the wild-type virus. A similar domain swap was carried out exchanging 67 amino acids from Z␣ DLM1 ( Fig. 1 b and c) for 67 amino acids at the N terminus of E3L. In this case, 12 residues remain unchanged, including those that bind to Z-DNA (11) . Again, the Z␣ DLM1 -E3L C chimera is fully pathogenic (Fig. 2) . Thus, only a small number of essential residues within the N-terminal domain of E3L are sufficient for biological activity, as measured by lethality.
Mutations in the Z␣ADAR1-E3LC Chimeric Virus. We next assayed point mutations in the Z␣ ADAR1 chimeric construct of E3L and compared the effect of these mutations on pathogenicity. We also measured the effect of Z␣ ADAR1 protein and its mutants on Z-DNA binding by using CD (14) . Residues were selected that are known to be important for Z-DNA binding, as seen in the cocrystal structures (10, 11) . As shown in Fig. 1a , tyrosine 177 forms an important interaction in recognizing Z-DNA, making an edge-to-face contact between the C8 atom of guanine 4 in the syn-conformation and the planar face of the tyrosine. In addition, the tyrosine hydroxyl group forms a hydrogen bond with a Z-DNA phosphate group. Two different mutations in tyrosine 177 were made in the Z␣ ADAR1 -E3L C chimeric vaccinia virus and in the Z␣ ADAR1 protein domain. (10) and mouse Z␣DLM1 (11) . A number of poxvirus E3L sequences are listed, as is the related sequence of human Z␤ ADAR1. Yellow bars indicate residues important for the protein fold (red dots) and for Z-DNA recognition (blue triangles). The amino acid numbering at the beginning and the end of each sequence is indicated. The GenBank accession numbers for the various sequences are as follows: double-stranded RNA adenosine deaminase, AAB06697.1 (Homo sapiens); Z-DNA-binding protein 1; tumor stroma and activated macrophage protein DLM-1 (Mus musculus) NP067369; the E3L proteins, AAA02759 (vaccinia virus); NP042088 (variola virus); AAC08018 (orf virus); AAK84995 (lumpy skin disease virus); NP570192 (Swinepox); NP073419 (yaba-like disease virus); and CAC42100 (cowpox virus). (c) Three different families of proteins are illustrated, with domains shown as colored boxes. The Z␣ and Z␤ domains of both ADAR1 and DLM1 are blue, as is the related domain of E3L. Vaccinia E3L protein and the editing enzyme ADAR1 both have domains that bind to double-stranded RNA, shown in red. Fig. 3a shows viral pathogenicity and the CD changes associated with these mutations. The change in the CD spectrum reflects the stabilization of the oligomer in the Z conformation, requiring conformationally specific binding of the protein to Z-DNA. When tyrosine 177 is mutated to phenylalanine (Y177F), the binding affinity is weakened by the loss of the hydroxyl group, and the CD spectral change is slower than that seen for the wild-type sequence. A tyrosine-to-alanine mutation (Y177A) has an even more dramatic effect on the spectrum, with a much slower and less complete conversion corresponding to weaker binding of the protein. We have also measured the dissociation constant (K d ) of the interaction with Z-DNA of all three constructs by using surface plasmon resonance, as described (4). For this measurement, poly[(dG-dC)] is partially brominated to stabilize it in the Z-DNA conformation. The K d of Z␣ ADAR1 protein for Z-DNA is 40 nM, Y177F reduces the K d to 350 nM, and Y177A reduces the K d further to 700 nM.
The effect of mutating tyrosine 177 in Z␣ ADAR1 of the chimeric E3L virus is presented in Fig. 3a. For example, at a viral dose of 100 plaque-forming units (pfu), 100% of the animals infected with vaccinia virus containing the Z␣ ADAR1 -E3L C chimera have died, consistent with the results shown in Fig. 2 . However, the chimera in which tyrosine 177 was changed to alanine (Y177A) was Ϸ1,000 times or 3 log 10 s less pathogenic than the unmutated Z␣ ADAR1 chimeric virus. The mutation to phenylalanine is Ϸ10 times, or 1 log 10 less pathogenic. The results support a strong dependence of pathogenicity on Z-DNA binding.
When comparing the K d values, the CD results, and the pathogenicity of these three constructs, it should be noted that each assay measures a somewhat different thing. K d measurements using surface plasmon resonance reflect the affinity of the Z-DNA-binding protein for preformed Z-DNA in a brominated substrate (4) . The CD assay requires a conversion of the right-handed B-DNA into left-handed Z-DNA followed by binding (14) (15) (16) . In vivo binding may also reflect other factors such as substrate accessibility, which affects Z-DNA-binding kinetics; therefore, it is not surprising that the results are not numerically proportional. Nevertheless, there is a strong correlation between the trends in pathogenicity, K d , and the ability to effect a B-DNA to Z-DNA conversion as monitored by CD for these mutants.
We then compared the importance of amino acid side chains that interact with Z-DNA in the cocrystal structure and those that do not (Fig. 3b) . As shown in Fig. 1a , lysine 169 (K169) forms a hydrogen bond to a phosphate group (10) , but the second residue along the recognition helix, glutamic acid 171 (E171, not shown in Fig. 1a ) does not interact with Z-DNA. Glutamine 186 (Q186) on the ␤-sheet also does not interact with Z-DNA. These residues were each mutated to alanine with strikingly different results. Mutant K169A Z␣ ADAR1 protein converts d(CG) 6 from B-DNA to Z-DNA more slowly and less completely, compared with unmutated Z␣ ADAR1 protein, whereas the rates of conversion of both E171A and Q186A mutant Z␣ ADAR1 proteins are comparable to that observed with the unmutated Z␣ ADAR1 (Fig.  3b) . Fig. 3b also shows that chimeric virus with Z␣ ADAR1 substituted for the N-terminal domain is indistinguishable in lethality from viruses with the mutations Q186A and E171A. In contrast, the mutation K169A in Z␣ ADAR1 protein has decreased ability to bind to Z-DNA as illustrated in the CD spectrum, and it also has markedly reduced pathogenicity: all animals live longer, and 75% of them survive in the 12-day experiment. Once again, mutations that weaken Z-DNA binding yield weakened virulence, whereas those that do not influence Z-DNA binding do not affect virulence. The virulence results for individual mutations of non-Z-DNA-binding residues are compatible with those for the numerous collective changes in Ͼ50 amino acids occurring in the substitution of Z␣ ADAR1 or Z␣ DLM1 for Z E3L, as described in Fig. 2 .
Comparison of Mutations in ZE3L and Z␣ADAR1. The in vivo effects of mutations in Z␣ ADAR1 -E3L C chimeric viruses were then compared with mutations of the analogous positions of wild-type vaccinia virus E3L (Z E3L ). Tyrosine 48 (Y48) of E3L, which is analogous to tyrosine 177 (Y177) of Z␣ ADAR1 (Fig. 1b) , was mutated to phenylalanine and alanine. The results, shown in Fig. 4a , can be compared with the results for chimeric Z␣ ADAR -E3L C in Fig. 3a . In each case, the tyrosine-to-phenylalanine mutation results in an Ϸ1 log 10 loss of pathogenicity compared with wild-type virus, whereas the alanine mutation causes an Ϸ3 log 10 change. The biological effects are thus similar for these mutations in the chimeric virus (Z␣ ADAR1 -E3L C ) and in the wild-type virus.
A pair of prolines (P192, P193) are found in the ␤ turn of Z␣ ADAR1 and make van der Waals contacts at the periphery of the Z-DNA-binding surface, as shown in Fig. 1a . These residues are essential for Z-DNA binding, especially P192, as shown in a Southwestern assay (17) . Proline 192 of Z␣ ADAR1 is in the cis conformation and makes extensive van der Waals contact with a phosphate group (10) . Fig. 4b shows that the P193A mutation of Z␣ ADAR1 -E3L C decreases lethality by 1-2 log 10 s. The P64A mutation in the analogous position of wild-type virus also decreases lethality by 1-2 log 10 s. Mutating proline 192 to alanine has a far more deleterious effect on pathogenicity, yielding a virus that is Ϸ4 log 10 s less virulent than the unmutated chimeric virus E3L. Likewise, P63A yields a virus that is 4-5 log 10 s less virulent. In another experiment, mutation K40A in wild-type virus, analogous to K169A in Z␣ ADAR1 (Fig. 3b) , also produces a less virulent phenotype (results not shown). All of these experiments reinforce the correlation of Z-DNA binding of E3L with pathogenicity in vaccinia virus. The N terminus of the vaccinia E3L protein can be functionally replaced by Z-DNA-binding domains from ADAR1 and DLM1. Chimeric viruses were created with either Z␣ ADAR1 or Z␣DLM1 at the E3L N terminus and wildtype E3L sequences at the C terminus. In these and subsequent experiments, groups of four to six C57BL͞6 mice (4 -6 weeks old) were infected intracranially with the indicated number of pfu of vaccinia virus constructs in 10 l unless otherwise specified. The method has been described (2). One hundred pfu were used in this experiment and the mice were monitored for mortality for 2 weeks. Data for wild-type vaccinia virus are a composite of four different experiments, each with four mice. Percent survival is plotted against days postinfection. WT, wild-type E3L; E3L⌬83N has 83 amino acids deleted from the N terminus, and Z␣ ADAR1 and Z␣DLM1 are chimeric viruses Z␣ADAR1-E3LC and Z␣ DLM1-E3LC , respectively.
Gain-of-Function Mutation for Z-DNA Binding Increases Pathogenicity.
The experiments described in Figs. 3 and 4 show mutations that weaken Z-DNA binding also decrease pathogenicity or virulence of the virus. Those changes produce a loss of function. Here we start with an inactive chimera, containing an N-terminal domain that does not bind Z-DNA and mutate it to simultaneously create both Z-DNA binding and biological activity. Human Z␤ ADAR1 is a domain of ADAR1 with many sequence features of the Z␣ family; however, it lacks several residues important for Z-DNA binding (Fig. 1b) . Furthermore, it does not bind Z-DNA (ref. 16 ; Y.-G.K. and A.R., unpublished work), and it does not alter the CD spectrum of d(CG) 6 (Fig. 5) . Fourteen residues are conserved in the Z␤ ADAR1 -E3L C chimeric virus, as compared with wild-type E3L. This result is comparable to the number conserved in the Z␣ ADAR1 -E3L C construct, but the results are entirely different. The Z␤ ADAR1 -E3L C chimera is not pathogenic to mice, even when 10 6 pfu are inoculated intracranially (Fig. 5) . This finding further supports the correlation between lack of Z-DNA binding and lack of pathogenicity.
It is possible to mutate Z␤ ADAR1 to produce a Z-DNA binding protein. Human Z␤ ADAR1 lacks the tyrosine residue in the binding interface analogous to Y177 in hZ␣ ADAR1 (Fig. 1b) . When isoleucine 335 is changed to tyrosine, the resulting protein, Z␤ ADAR1 I335Y binds Z-DNA. Fig. 5 shows the conversion of B-DNA to Z-DNA in the presence of Z␤ ADAR1 I335Y protein as monitored by CD. The Z␤ ADAR1 I335Y-E3L C chimeric virus shows significant pathogenicity when inoculated into mice, although less than wild-type virus or the Z␣ ADAR1 -E3L C chimera. The gain of Z-DNA binding in the mutated protein domain correlates well with the gain of biological function in the mutated chimeric virus. (26) . Z␣ADAR1 protein converts the oligonucleotide to the Z-DNA conformation quite rapidly, and the mutants Y177F and Y177A affect the conversion at increasingly slower rates, corresponding to the weakened pathogenicity of the relevant viral constructs. (b) The lethality after intracranial inoculation of 100 pfu is shown for wild-type and a number of chimeric E3L vaccinia viruses, with the indicated mutations. Wild-type virus, chimeric Z␣ ADAR1-E3LC virus, and chimeric virus with Q186A or E171A mutations are all equally lethal. In contrast, the K169A mutant shows decreased virulence with considerable survival. The CD is shown (Right). Z␣ ADAR1 protein and the Q186A and E171A mutants rapidly convert d(CG) 6 to the Z-DNA form. The K169A mutant achieves only partial conversion and at a slower rate.
Discussion
It is likely that Z-DNA binding is a common feature of E3L gene products in poxviruses. The N-terminal E3L domains have been expressed from vaccinia, orf, lumpyskin, swinepox, and yaba-like disease viruses (Fig. 1b) . All of them show specificity for binding to Z-DNA in vitro, but with varying affinities (Y.-G.K. and A.R., unpublished work). In vivo Z-DNA binding can be assayed by using a yeast one-hybrid system. The reporter gene, ␤-galactosidase, is expressed when Z␣ ADAR1 fused to an activation domain is transfected into a cell containing a Z-DNA-forming sequence upstream of the reporter gene (18) . Using this system, Z E3L shows comparable Z-DNA-binding activity as Z␣ ADAR1 or Z␣ DLM1 (Y.-G.K. and A.R., unpublished work).
Although the experiments presented here focused on Z-DNA binding, that is clearly an oversimplification. Vaccinia E3L has been implicated in at least four possible roles, which may be important for viral pathogenesis: Z-DNA binding, nuclear localization, IFN-blocking activities, and higher-order oligomerization (2). Likewise, a nuclear export signal has been localized in the ⌮␣ ADAR1 domain, which is important for nuclearcytoplasmic shuttling of ADAR1 (19, 20) . This signal, which does not involve the Z-DNA-binding residues, could result in a lower nuclear concentration of chimeric Z␣ ADAR1 -E3L C protein. Any or all of these functions may modulate the biological activity of the N terminus of E3L in both wild-type and chimeric viruses. However, the experiments described here have focused on the essential contribution of Z-DNA binding.
The E3L molecule has two theaters of operation. In the cytoplasm of the cell where the virus replicates, it plays an important role in inhibiting the activity of proteins involved in the IFN response. The IFN-induced protein kinase, PKR, binds to double-stranded RNA and acts to phosphorylate, and thereby inactivate the protein synthesis initiation factor eIF2␣. The E3L proteins are potent inhibitors of PKR (21), requiring both domains for full inhibition (refs. 7 and 22; J. O. Langland and B.L.J., unpublished work). Likewise, E3L blocks the activation of the 2Ј-5Ј oligoadenylate synthase (23, 24) . E3L has recently been shown to inhibit induction of IFN-␤ by blocking phosphorylation of the transcription factor IRF-3 (8, 9) . Thus, E3L acts in the cytoplasm to broadly block the IFN system.
It is known that E3L also accumulates in the nucleus (6, 25) , but little is known about its activities there. For instance, we do not know the target of E3L in the nucleus. It is likely that the N terminus of E3L is binding to Z-DNA in the nucleus, but we cannot rule out binding to Z-form double-stranded RNA (26) . Z-DNA is a left-handed conformation of the double helix stabilized by negative supercoiling (14) , and many human genes have sequences favoring Z-DNA formation near the transcription start site (27) . Movement of RNA polymerase along DNA generates negative supercoiling behind it, which can be sufficient to stabilize the left-handed Z-conformation, then reverting to the right-handed B-conformation when transcription ceases (28) . Z-DNA is thus a transient conformational change associated with actively transcribing genes (29). The knowledge that E3L consists of two domains, a Z-DNAbinding domain at the N terminus and a double-stranded RNA-binding domain at the C terminus, offers a possible clue to its activity in the nucleus. Both of these domains bind with conformational specificity, but not sequence specificity, suggesting that E3L acts at multiple sites. Z-DNA-forming sequences found near the transcription start site (27) can flip into the Z-conformation in some actively transcribing genes (28, 29) , and E3L may bind to the Z-DNA segment of such genes. The double-stranded RNA-binding motif might then be available to bind to a foldback or transient hairpin structure of the premRNA. This action could have the effect of decreasing the extent to which selected genes in the host cell can respond to the viral infection, either by impairing transcription or by interfering with the splicing apparatus. Such a mechanism would represent yet another example of the way in which the virus uses features of the host cell to prevent it from maintaining an antiviral defense.
The structures of Z␣ ADAR1 and Z␣ DLM1 bound to Z-DNA are known, and by analogy we can infer something about the conformation of the Z-DNA-binding pocket in the N-terminal domain of the vaccinia E3L molecule. Future structural studies are needed to confirm the nature of the binding pocket. The yeast one hybrid system (18) requires Z-DNA binding to activate the reporter gene. This could be the basis of an assay system to develop a molecule that would attach selectively to the binding pocket. Treating a mouse with such a molecule could interfere with E3L Z-DNA binding and prevent the lethality associated with vaccinia infection. Likewise, some people have adverse reactions to vaccination with vaccinia virus. A molecule-blocking E3L binding may halt the progress of the virus and play a useful role in minimizing these reactions. Because this Z-DNA-binding pocket occurs rarely in host cell proteins, interfering with Z-DNA binding might have only minimal adverse effects.
Comparison of the sequence of the E3L molecule of variola, the agent of smallpox, with that of vaccinia reveals that the molecules are essentially identical (Fig. 1b) . None of the residues that differ are found near the Z-DNA-binding site. A small molecule binding to variola E3L may prevent its pathology and be effective in treating smallpox.
